Related Experiment Video
Updated: May 6, 2026
07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
6.8K
Insights into thymic involution in tumor-bearing mice
Roberto Carrio1, Diana M Lopez
1Department of Microbiology and Immunology, University of Miami Miller School of Medicine, P.O. Box 016960 (R-138), Miami, FL, 33101, USA, rcarrio@med.miami.edu.
Immunologic Research
|November 8, 2013
Summary
Tumor development can impair T-cell development and cause thymic involution, a process where the thymus shrinks. Understanding these mechanisms is key to developing cancer therapies that combat immune suppression.
Area of Science:
- Immunology
- Oncology
- Cellular Biology
Background:
- The thymus is vital for T-cell development and adaptive immunity.
- Thymic involution, or shrinkage, occurs in various conditions like aging and disease.
- Mechanisms of tumor-induced thymic involution are not fully understood.
Purpose of the Study:
- To review findings on cell-mediated immunity in a mammary tumor model.
- To investigate tumor-induced T-cell development impairment and thymic involution.
Main Methods:
- Review of studies focusing on cell-mediated immunity.
- Analysis of a mammary tumor model to observe T-cell development and thymic changes.
Main Results:
- Mammary tumors were observed to impair T-cell development.
- Tumor development was linked to thymic involution.
Conclusions:
- Understanding tumor-induced thymic involution is crucial for developing cancer therapies.
- Targeting these mechanisms may help overcome tumor-induced immune suppression.
